Alnylam Pharmaceuticals
ALNY
#854
Rank
HK$236.84 B
Marketcap
HK$1,770
Share price
0.72%
Change (1 day)
-47.55%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company